University of California, Davis
Evaluation of current and newly developed endoluminal therapies in the management of Upper and Lower GI conditions.
Over the last few years there have been numerous advances in the use of endoscopic equipment and related treatments in the identification and intervention of gastrointestinal diseases. Many of these treatments using flexible endoscopes have either complimented or replaced surgical approaches to these same benign and malignant disease processes with the potential of being the standard of care for many of these clinical conditions. The initial primary focus of this study will be the use of endoscopic myotomy for achalasia, endoscopic treatment of post bariatric weight gain, endoscopic gastro-gas…
Inclusion Criteria: * Adult male and female patients 18-80 years of age * Meet the criteria for surgery of benign and/or malignant gastrointestinal pathology(s) * Gastrointestinal Reflux Disease * Achalasia * Barrett's Esophagus * Post Bariatric Surgery conditions * Other gastrointestinal and postsurgical disorders. Exclusion Criteria: * Adults unable to consent * Individuals that do not meet inclusion criteria or qualify for endoluminal treatment paradigms and internees.
After reviewing all therapeutic options the patient will be offered the best therapeutic option to treat their condition. Surgical interventions include open laparotomy, diagnostic/therapeutic laparoscopy or endoluminal therapies. After the patient is consented for the related surgical intervention the patient will be given the option to participate in the clinical study to measure outcomes after surgery.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.